• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西内脏利什曼iasis 流行地区有症状和无症状 HIV-利什曼原虫合并感染个体血清细胞因子水平比较。

Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.

机构信息

Department of Parasitology, Aggeu Magalhães Institute-Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil.

Curso de medicina, Núcleo de Ciências da Vida, Centro Acadêmico do Agreste, Universidade Federal de Pernambuco, Caruaru, Pernambuco, Brazil.

出版信息

PLoS Negl Trop Dis. 2022 Jun 17;16(6):e0010542. doi: 10.1371/journal.pntd.0010542. eCollection 2022 Jun.

DOI:10.1371/journal.pntd.0010542
PMID:35714136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9246190/
Abstract

BACKGROUND

Visceral leishmaniasis (VL) remains an important infectious disease worldwide. VL-HIV coinfected individuals can present with atypical clinical forms of VL and have a high risk of VL relapse. Some cytokines have been described as potential markers to diagnose active VL and to predict the severity of the cases. However, few studies have included VL-HIV coinfected patients. We aimed to characterize the levels of several cytokines among VL-HIV coinfected individuals living in a VL-endemic area in Northeast Brazil.

METHODS

This was a retrospective, cross-sectional study, aiming to estimate the levels of various cytokines in symptomatic and asymptomatic VL-HIV coinfected individuals. There were 134 study participants (35 symptomatic VL-HIV, 75 asymptomatic VL-HIV, and 24 healthy controls), all ≥ 18 years-old. Serum cytokine levels (interferon-γ, tumor necrosis factor, and interleukins 2, 4, 6, 10, and 17A) were quantified using the Becton Dickinson-BD's Cytometric Bead Array (CBA) system.

RESULTS

The population mainly consisted of men (64.9%), with a median age of 35 (27-41) years. Asymptomatic individuals were younger (p = 0.013), with more years of education (p < 0.001), and were more often on antiretroviral therapy (p < 0.001) than those in the symptomatic group. Hemoglobin levels (p < 0.001), lymphocytes (p < 0.001) and CD4 count (p < 0.001) were lower in symptomatic individuals, while HIV viral loads were higher (p < 0.001). In the symptomatic VL-HIV coinfected group, we observed increased serum levels of IL-17A, IL-6, and IL-10 compared to asymptomatic patients and the healthy controls. There were no differences in the levels of all cytokines between asymptomatic VL-HIV coinfected individuals and the healthy controls.

CONCLUSIONS

Higher serum levels of IL-17A, IL-6, and IL-10 cytokines were observed in symptomatic coinfected individuals but not in asymptomatically infected individuals. More studies among HIV-positive persons are needed to better understand the role of serum cytokines for prognosis, to define cure and predict VL relapses in VL-HIV coinfected individuals.

摘要

背景

内脏利什曼病(VL)仍然是全球重要的传染病。VL-HIV 合并感染的个体可能表现出非典型的 VL 临床形式,并且具有较高的 VL 复发风险。一些细胞因子已被描述为诊断活动性 VL 和预测病例严重程度的潜在标志物。然而,很少有研究包括 VL-HIV 合并感染的患者。我们旨在描述生活在巴西东北部 VL 流行地区的 VL-HIV 合并感染个体中几种细胞因子的水平。

方法

这是一项回顾性、横断面研究,旨在估计有症状和无症状 VL-HIV 合并感染个体中各种细胞因子的水平。共有 134 名研究参与者(35 名有症状的 VL-HIV、75 名无症状的 VL-HIV 和 24 名健康对照),年龄均≥18 岁。使用 Becton Dickinson-BD 的 Cytometric Bead Array(CBA)系统定量血清细胞因子水平(干扰素-γ、肿瘤坏死因子以及白细胞介素 2、4、6、10 和 17A)。

结果

该人群主要由男性(64.9%)组成,中位年龄为 35(27-41)岁。无症状个体更年轻(p=0.013),受教育程度更高(p<0.001),并且更常接受抗逆转录病毒治疗(p<0.001)。与有症状组相比,无症状个体的血红蛋白水平(p<0.001)、淋巴细胞计数(p<0.001)和 CD4 计数(p<0.001)更低,而 HIV 病毒载量更高(p<0.001)。在有症状的 VL-HIV 合并感染组中,与无症状患者和健康对照组相比,我们观察到血清中 IL-17A、IL-6 和 IL-10 水平升高。无症状 VL-HIV 合并感染个体与健康对照组之间的所有细胞因子水平无差异。

结论

在有症状的合并感染个体中观察到更高的血清 IL-17A、IL-6 和 IL-10 细胞因子水平,但在无症状感染个体中未观察到。需要对 HIV 阳性人群进行更多研究,以更好地了解血清细胞因子在预后、确定治愈和预测 VL-HIV 合并感染个体复发中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24b/9246190/7c440e3d2736/pntd.0010542.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24b/9246190/758bdd04087a/pntd.0010542.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24b/9246190/7c440e3d2736/pntd.0010542.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24b/9246190/758bdd04087a/pntd.0010542.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24b/9246190/7c440e3d2736/pntd.0010542.g002.jpg

相似文献

1
Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.巴西内脏利什曼iasis 流行地区有症状和无症状 HIV-利什曼原虫合并感染个体血清细胞因子水平比较。
PLoS Negl Trop Dis. 2022 Jun 17;16(6):e0010542. doi: 10.1371/journal.pntd.0010542. eCollection 2022 Jun.
2
Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.巴西伯南布哥州接受抗逆转录病毒治疗的 HIV 阳性门诊患者中的无症状利什曼病感染。
PLoS Negl Trop Dis. 2021 Jan 21;15(1):e0009067. doi: 10.1371/journal.pntd.0009067. eCollection 2021 Jan.
3
Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.巴西伯南布哥州住院 HIV 感染患者内脏利什曼病。
Am J Trop Med Hyg. 2018 Dec;99(6):1541-1546. doi: 10.4269/ajtmh.17-0787.
4
Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients.HIV 合并无症状和有症状内脏利什曼病患者血清可溶性 CD40 配体和新蝶呤水平。
Front Cell Infect Microbiol. 2018 Dec 11;8:428. doi: 10.3389/fcimb.2018.00428. eCollection 2018.
5
Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context.无症状和有症状的人类在 Mediterranean 环境中作为内脏利什曼病储主的作用。
PLoS Negl Trop Dis. 2020 Apr 23;14(4):e0008253. doi: 10.1371/journal.pntd.0008253. eCollection 2020 Apr.
6
Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia.抗原尿预测内脏利什曼病/艾滋病毒合并感染患者初始治疗失败和复发:埃塞俄比亚临床试验中的一项嵌套探索性研究。
Front Cell Infect Microbiol. 2018 Mar 29;8:94. doi: 10.3389/fcimb.2018.00094. eCollection 2018.
7
HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.人类免疫缺陷病毒1型会改变辅助性T细胞细胞因子、白细胞介素-12和白细胞介素-18对原生动物寄生虫杜氏利什曼原虫的反应。
AIDS. 2000 May 26;14(8):921-9. doi: 10.1097/00002030-200005260-00003.
8
Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.利什曼原虫 - 艾滋病毒合并感染:巴西一个城市地区的临床表现和结局。
PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2816. doi: 10.1371/journal.pntd.0002816. eCollection 2014 Apr.
9
Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?巴西东北部内脏利什曼病:HIV 对这种原生动物感染的影响是什么?
PLoS One. 2019 Dec 5;14(12):e0225875. doi: 10.1371/journal.pone.0225875. eCollection 2019.
10
New world Leishmania spp. infection in people living with HIV: Concerns about relapses and secondary prophylaxis.新出现的世界利什曼原虫属感染与 HIV 感染者:对复发和二级预防的关注。
Acta Trop. 2021 Dec;224:106146. doi: 10.1016/j.actatropica.2021.106146. Epub 2021 Sep 23.

引用本文的文献

1
Immune-Pathological Correlates of Disease Severity in New-World Kala-Azar: The Role of Parasite Load and Cytokine Profiles.新大陆黑热病疾病严重程度的免疫病理学关联:寄生虫负荷和细胞因子谱的作用
Pathogens. 2025 Jun 20;14(7):615. doi: 10.3390/pathogens14070615.
2
Insights to the HIV-associated visceral leishmaniasis clinical outcome: lessons learned about immune mediated disorders.对HIV相关内脏利什曼病临床结局的见解:关于免疫介导疾病的经验教训。
Front Immunol. 2025 Mar 12;16:1516176. doi: 10.3389/fimmu.2025.1516176. eCollection 2025.
3
Immune response to viscerotropic : a comprehensive review.

本文引用的文献

1
Evaluation of medullary cytokine expression and clinical and laboratory aspects in severe human visceral leishmaniasis.严重内脏利什曼病患者骨髓细胞因子表达与临床和实验室特征评估。
Parasite Immunol. 2021 Dec;43(12):e12880. doi: 10.1111/pim.12880. Epub 2021 Oct 11.
2
Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia.内脏利什曼病患者在埃塞俄比亚南部阿尔巴明奇综合医院就诊期间,在不同寄生虫血症水平下,于治疗前后的抗体和细胞因子水平。
PLoS Negl Trop Dis. 2021 Aug 5;15(8):e0009632. doi: 10.1371/journal.pntd.0009632. eCollection 2021 Aug.
3
内脏亲嗜性的免疫应答:全面综述。
Front Immunol. 2024 Sep 18;15:1402539. doi: 10.3389/fimmu.2024.1402539. eCollection 2024.
4
An integrated analysis of the structural changes and gene expression of spleen in human visceral leishmaniasis with and without HIV coinfection.人类内脏利什曼病合并与不合并 HIV 感染的脾脏结构变化和基因表达的综合分析。
PLoS Negl Trop Dis. 2024 Jun 6;18(6):e0011877. doi: 10.1371/journal.pntd.0011877. eCollection 2024 Jun.
5
CD4 Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis.CD4 Th1 和 Th17 反应以及多功能 CD8 T 淋巴细胞与人类内脏利什曼病的治愈或病情恶化有关。
Front Immunol. 2024 Feb 12;15:1277557. doi: 10.3389/fimmu.2024.1277557. eCollection 2024.
Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
巴西伯南布哥州接受抗逆转录病毒治疗的 HIV 阳性门诊患者中的无症状利什曼病感染。
PLoS Negl Trop Dis. 2021 Jan 21;15(1):e0009067. doi: 10.1371/journal.pntd.0009067. eCollection 2021 Jan.
4
Cytokine profile in Leishmania-positive blood donors.利什曼原虫阳性献血者的细胞因子谱。
PLoS One. 2020 Sep 23;15(9):e0238933. doi: 10.1371/journal.pone.0238933. eCollection 2020.
5
Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context.无症状和有症状的人类在 Mediterranean 环境中作为内脏利什曼病储主的作用。
PLoS Negl Trop Dis. 2020 Apr 23;14(4):e0008253. doi: 10.1371/journal.pntd.0008253. eCollection 2020 Apr.
6
Serum profile of IL-1β and IL-17 cytokines in patients with visceral leishmaniasis.内脏利什曼病患者血清中白介素-1β和白介素-17 细胞因子的变化
Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101431. doi: 10.1016/j.cimid.2020.101431. Epub 2020 Feb 7.
7
Asymptomatic immune responders to Leishmania among HIV positive patients.HIV 阳性患者中无症状利什曼原虫免疫应答者。
PLoS Negl Trop Dis. 2019 Jun 3;13(6):e0007461. doi: 10.1371/journal.pntd.0007461. eCollection 2019 Jun.
8
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.细胞因子:内脏利什曼病耐药或疾病进展的关键决定因素:新型诊断和免疫治疗的机会。
Front Immunol. 2019 Apr 5;10:670. doi: 10.3389/fimmu.2019.00670. eCollection 2019.
9
Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens.内脏利什曼病:诊断和治疗方案的最新进展。
Infect Dis Clin North Am. 2019 Mar;33(1):79-99. doi: 10.1016/j.idc.2018.10.005.
10
Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.巴西伯南布哥州住院 HIV 感染患者内脏利什曼病。
Am J Trop Med Hyg. 2018 Dec;99(6):1541-1546. doi: 10.4269/ajtmh.17-0787.